Sucampo Pharmaceuticals, Inc. Stock

Stocks

17-12-26	Wall Street slips on tech sector weakness	RE
17-12-26	Mallinckrodt : to buy Sucampo for about $840 million	RE
16-11-09	Boeing : U.S. companies react cautiously to Trump victory	RE

18-01-03	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-12-29	SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc	BU
17-12-28	CORRECTING and REPLACING Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-12-27	SUCAMPO PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-11-27	Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference	GL

17-12-26	Apple : POINT Marchés-Wall Street finit peu changée, freinée par Apple
17-12-26	Apple : Les valeurs à suivre à Wall Street
17-12-08	Alexion Pharmaceuticals : Les valeurs à suivre à Wall Street
17-12-07	Sucampo Pharmaceuticals : La biotech américaine Sucampo envisage de se vendre
17-04-19	Sucampo Pharmaceuticals : Veröffentlichung einer neuen Studie zu VTS-270 für die Behandlung von Morbus Niemann-Pick Typ C1 im Online-Fachjournal PLOS ONE Advances Science

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUCAMPO PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	+1.52%	-7.16%	+51.66%	+67.41%	65B
LONZA GROUP AG	+1.23%	+6.20%	+10.24%	+78.25%	51.2B
ARGENX SE	+0.63%	-0.11%	+0.33%	+62.47%	51.19B
IQVIA HOLDINGS INC.	-0.68%	+1.12%	+25.03%	+41.97%	43.93B
BEONE MEDICINES AG	+0.20%	+5.51%	+16.04%	+133.00%	41.96B
REVOLUTION MEDICINES, INC.	+1.84%	-6.90%	+234.31%	+522.62%	38.14B
CELLTRION, INC.	+2.16%	+10.36%	+18.92%	+59.70%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	+1.80%	25.2B
GENMAB A/S	+1.60%	+2.21%	+27.96%	+28.00%	22.5B
Average	+0.74%	+0.14%	+46.84%	+110.58%	41.37B
Weighted average by Cap.	+0.86%	+0.04%	+45.12%	+111.73%